|
Slide |
Credits |
1 |
History |
2 |
PMH, PSH, Allergies, Meds |
3 |
SH, FH, ROS |
4 |
Physical Exam |
5 |
|
6 |
Admit Labs |
7 |
Hospital Course |
8 |
Admit CXR-PA |
9 |
Admit CXR-Lat |
10 |
Admit CXR-Close-up |
11 |
CXR-5 yrs ago |
12 |
Path Slides |
13 |
|
14 |
|
15 |
|
16 |
|
17 |
|
18 |
Admit CXR |
19 |
Chest Thorax |
20 |
Solitary Pulmonary Nodule (SPN) |
21 |
Diagnosis |
22 |
|
23 |
|
24 |
Diagnostic Labs |
25 |
PFT's |
26 |
Radiographic Eval |
27 |
|
28 |
Indications for Chest CT |
29 |
CT |
30 |
FDG Position Emission Tomography |
31 |
CT-FDG PET Scan |
32 |
CXR prior to PET |
33 |
CT prior to PET |
34 |
CT-FDG PET Scan |
35 |
FDG PET |
36 |
|
37 |
|
38 |
Therapeutic Decisions |
39 |
Bayesian Analysis 80's |
40 |
|
41 |
|
42 |
Probability of Malignancy of SPN 90's |
43 |
Therapeutic Decisions |
44 |
Biopsy of SPN |
45 |
Surgery |
46 |
Back to Patient |
47 |
Hospital Course |
48 |
|
49 |
Probability of Malignancy |
50 |
Decision Made |
51 |
Coccidioidomycosis |
52 |
|
53 |
|
54 |
|
55 |
Clin Findings |
56 |
|
57 |
Dx of Coccidioidomycosis |
58 |
|
59 |
|
60 |
|
61 |
Extrapulmonary Dissemination |
62 |
Risk Factors for Dissemination |
63 |
|
64 |
Uncomplicated Infections |
65 |
Monitoring |
66 |
Antifungal Therapy |
67 |
Indicators for Severity |
68 |
Antifungal Therapy |
69 |
Chronic Pulm Coccidioidomycosis |
70 |
|
71 |
Nodules & Cavities |
72 |
Management of Coccidioidomycosis |
73 |
|
74 |
Back to our Patient |
75 |
Post-op Course |
76 |
References |
77 |
Thank you |
78 |